|Date:||Wednesday, August 7, 2013|
|Time:||11:00 am EDT|
|Dial-in numbers:||(877) 303-9483 (U.S. & Canada) or (760) 666-3584|
|Live webcast:||www.columbialabs.com, under 'Investor'|
Columbia Laboratories, Inc. (NasdaqCM: CBRX) will hold a conference call on August 7, 2013, to discuss financial results of the second quarter ended June 30, 2013. Frank Condella, President and Chief Executive Officer, and Jonathan Lloyd Jones, Vice President and Chief Financial Officer of Columbia Laboratories, will host the call.
The teleconference replay will be available two hours after completion through Monday, August 12, 2013, at (855) 859-2056 (U.S. & Canada) or (404) 537-3406. The conference ID for the replay is 21285162. The archived webcast will be available for one year on the Company's website, www.columbialabs.com, in the 'Investor' section under 'Events'. About Columbia Laboratories Columbia Laboratories, Inc. is a publicly traded specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women’s health indications. For more information, please visit www.columbialabs.com.